publication date: Feb. 19, 2021
To access this members-only content, please log in.Institutional subscribers, please
log in with your IP.
If you're not a subscriber why not
join today? To gain access to the members only content
click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.
Imagine a future where cancer patients are able to receive the treatment they precisely need and not the treatment that is prescribed to all.
In a matter of months, cancer researchers have gone from grappling with a surge of COVID-19 with limited clinical data to playing a critical role in the development of successful mRNA vaccines against the disease.
As she became president of the American Society of Clinical Oncology, Lori J. Pierce decided to focus on equity in cancer care as her year-long presidential theme.
Sometime in 1995, Edith Mitchell, a U.S. Air Force oncologist who at the time served as commander of the 131st Medical Squadron at Lambert-St. Louis International Airport, first heard the name Jane Cooke Wright.
This column in The Cancer Letter features the latest posts to the Cancer History Project by our growing list of contributors.
- Richard Nixon Foundation to commemorate National Cancer Act in a two day meeting
- Jeremy Kortmansky named associate CMO for Network Medical Services at Smilow
- Edward Kaftan named assistant cancer center director for translational science at Yale Cancer Center
- Daniel E. Spratt named chair of radiation oncology at University Hospitals Seidman Cancer Center
- Ute Dugan named SVP of clinical research at Parker Institute for Cancer Immunotherapy
- Paul Han named senior scientist of NCI’s Behavioral Research Program
- Carl June, Steven Rosenberg, Zelig Eshhar named 2021 Dan David Prize Laureates
- UCLA Health receives $29 million to establish center in precision genomic medicine
- Broad Institute, Dana-Farber, and Count Me In receive $16 million to launch patient-partnered research initiatives in rare cancers
- Biden administration: Work requirements in Medicaid do not promote the objectives of the program
- George Mason, Rutgers Cancer Institute collaboration receives $1.33M U.S. Army’s Breakthrough Award
A profound, difficult, seemingly impossible human journey begins with the words, “you have cancer.”
- NCCN guidelines analyze evidence for nephroblastoma
- Study: Cabozantinib found to be most effective treatment for metastatic papillary kidney cancer
- Gene-based blood test for melanoma spread evaluates treatment progress
- JNCCN study: Weight loss associated with worse outcomes in people with HER2+ early breast cancer
- Single-dose radiation therapy for breast cancer removes treatment barriers for Black women
- Yale study: Targeted therapy improves survival in advanced bladder cancer
- FDA approves Cosela to reduce bone marrow suppression caused by chemotherapy
- Exact Sciences to acquire Ashion Analytics, enter research collaboration with City of Hope’s Genomics Institute, TGen
